Our Favorite Incubator, Incubates! Telehealth in its Future?

True Nature|Mitesco has found an excellent first Company to incubate and help grow, called MyCare.The founders of the Minute Clinic are teaming up again...
Immuron, Superbug Stock Review

Adding Immuron (IMRN) $2.57 to Superbug Watchlist.

CLICK FOR LIVE QUOTE SUPER BUG STOCK REVIEW Prevent Montezuma's Revenge BEFORE it starts! Immuron's direct to consumer product Travelan® is a huge hit with international...

VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market Expand to Over...

Internet Stock Review Blast from the past scores big! We added VirnetX (VHC) to the Watch List (Patent Stock Review, since shuttered) back in 2010....
biotech stock review ATXI

Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted for Review by...

IV tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting. $2.00 to $10 in...

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News. Citius Pharma (CTXR) Inches Closer to the Next Phase III Data Announcement. Citius Pharma Presenting at...
Citius, Biotech Stock Review

Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial

PHASE III PROGRESS October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019 - Data Analysis Back, Results Positive.February...

Okay, so What’s Next for Citius Pharma (CTXR) $1.16?

Dawson James Broker/Dealer Updates. Price Target Remains at $7.00. "OK, So what’s Next? Topline data from the superior efficacy interim analysis should represent the next...
Citius Pharma

Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $4.00 (from $1.65) while maintaining a Buy rating. The analyst commented,...
coronavirus, biotech stock review

VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).

Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop the spread of coronavirus and to...

Stand Down V: MAGA. Each Crossing $1 Trillion, Microsoft, Amazon, Google, and AAPL.

Is this today's version of the Nifty 50? Microsoft $1.3 Trillion Apple $1.3 Trillion Google $1 Trillion Amazon $1 Trillion Biotech Stock Review: Biotech 5 Pack. 5 Biotech Stocks...

Latest article

Fairchild Gold (FAIR.V) Advances Towards Drilling.

Fairchild Gold Advances Toward Drilling at Nevada Titan as Geophysics Sharpens Porphyry Targeting Vancouver, British Columbia and Las Vegas, Nevada--(Newsfile Corp. - August 21, 2026)...
Hecla Mining, Institutional Gold Analyst

Hecla Mining (HL) $20.75 – Rips 33% Higher, on Incredible Numbers.

Shareholders Celebrate $4 Billion Gain in Market Value, in a Couple Weeks! And we'll drink to that! When we added Hecla Mining (HL) to the...
Mitesco Centcore

A Turnaround at Mitesco Coming? Mitesco Moves Into Mini-Data Centers.

Last Round (turnaround that is) worked great, back in 2019, Trading From $0.02 to $0.50. And no, we Didn't Sell a Single Share (waa)....